| | Class 2 Device Recall |  |
| Date Initiated by Firm | August 20, 2004 |
| Date Posted | October 28, 2004 |
| Recall Status1 |
Terminated 3 on June 09, 2005 |
| Recall Number | Z-0054-05 |
| Recall Event ID |
30013 |
| Product Classification |
Test, Thrombin Time - Product Code GJA
|
| Product | Fibriquik, bioMeriux, Inc., Box 15969, Durham, North Carolina 27704-0969 |
| Code Information |
Product number 235531, Lot number 113101, 113049, 113050 and Product number 235529, Lot number 111169 |
| FEI Number |
3002769706
|
Recalling Firm/ Manufacturer |
bioMerieux 100 Rodolphe St Bldg 1300 Durham NC 27712-9402
|
| For Additional Information Contact | Jocelyn Jennings 919-620-2968 |
Manufacturer Reason for Recall | Complaints were received from the field regarding prolonged clot times, high control values and erratic results. |
FDA Determined Cause 2 | Other |
| Action | Consignees were notified by letter on 8/20/2004. |
| Quantity in Commerce | 2406 units |
| Distribution | Nationwide, Australia, Brazil, Canada, China, Japan, Laos, Philippines, UK |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|